Livzon Pharmaceutical Group Inc.
000513
Pozycja w akcjach
#4688
Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and... Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and established in 1985, is a biopharmaceutical enterprise operating across the entire spectrum of pharmaceutical activities, from research and development to manufacturing and commercialization. The company's operations encompass a diverse range of finished drug products, active pharmaceutical ingredients (APIs), and chemical intermediates, primarily serving the Chinese market while also engaging in international exports. Its pharmaceutical portfolio includes treatments such as Ilaprazole enteric coated tablets for duodenal ulcers and reflux esophagitis, Laprazole sodium injection for managing peptic ulcer bleeding, Leuprorelin Acetate Microspheres for injection, and Urofollitropin injection for anovulation and fertility support. Livzon also produces Perospirone Hydrochloride for schizophrenia, Anti-viral Granules targeting upper respiratory tract infections and influenza, and Shenqi Fuzheng Injection, which addresses general weakness, fatigue, spontaneous sweating, and vertigo, and provides supportive care for lung and stomach cancer patients. Beyond therapeutic drugs, Livzon Pharmaceutical Group develops and distributes a variety of diagnostic reagents. These include kits for detecting IgM/IgG antibodies to coronavirus, nucleic acid tests for human immunodeficiency virus type 1, antinuclear antibody test kits, interferon-gamma release assay kits, and rapid tests for mycoplasma pneumoniae IgM antibodies. The company's extensive offerings further extend to biochemical drugs, microbiological preparations, biologics, traditional Chinese medicine formulations, pharmaceutical raw materials, and antibiotics.
Cena akcji
$3.90
Kapitalizacja rynkowa
$3.17B
Zmiana (1 dzień)
-3.49%
Zmiana (1 rok)
-25.88%
Kraj
CN
Handel Livzon Pharmaceutical Group Inc. (000513)
Kategoria
Healthcare
EPS dla Livzon Pharmaceutical Group Inc. (000513)
EPS na dzień June 2026 TTM: $0.28
Według najnowszych raportów finansowych i ceny akcji firmy Livzon Pharmaceutical Group Inc., obecny EPS (TTM) wynosi $0.28. Na koniec roku 2024 firma miała EPS w wysokości $0.31, wzrost w porównaniu do do EPS z roku 2023, który wynosił $0.30.
Historia EPS dla Livzon Pharmaceutical Group Inc. od 2001 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $0.28 | -11.56% |
| 2025 | $0.32 | 5.73% |
| 2024 | $0.31 | 3.44% |
| 2023 | $0.30 | 0.34% |
| 2022 | $0.30 | -1.07% |
| 2021 | $0.30 | 6.71% |
| 2020 | $0.28 | 40.33% |
| 2019 | $0.20 | 18.39% |
| 2018 | $0.17 | -77.05% |
| 2017 | $0.73 | 466.90% |
| 2016 | $0.13 | 13.68% |
| 2015 | $0.11 | 15.74% |
| 2014 | $0.10 | 3.03% |
| 2013 | $0.10 | 14.63% |
| 2012 | $0.08 | 22.29% |
| 2011 | $0.07 | -10.03% |
| 2010 | $0.08 | -7.56% |
| 2009 | $0.08 | 842.53% |
| 2008 | $0.01 | -89.04% |
| 2007 | $0.08 | 195.17% |
| 2006 | $0.03 | 80.54% |
| 2005 | $0.01 | -11.83% |
| 2004 | $0.02 | 7.64% |
| 2003 | $0.02 | 45.37% |
| 2002 | $0.01 | 27.06% |
| 2001 | $0.01 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| $6.55 | 2,213.50% |
DE
|
|
| $6.12 | 2,062.69% |
DE
|
|
| $0.72 | 155.51% |
JP
|
|
| $3.66 | 1,193.29% |
CH
|
|
| $0.53 | 88.59% |
IN
|
